Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 09-2004 | 06-2004 | |
| Sales | 0 | 1,600 | 2,540 |
| Gross Profit | N/A | 1,600 | 2,540 |
| Operating Expenses | 0 | 3,190 | 3,450 |
| Operating Income | N/A | -1,590 | -910 |
| Other Income | 0 | -480 | 40 |
| Pre-tax Income | 0 | -2,070 | -870 |
| Income Tax | N/A | 0 | 50 |
| Net Income Continuous | N/A | -2,070 | -920 |
| Net Income | $N/A | $-2,070 | $-920 |
| EBITDA(a) | $N/A | $-1,340 | $-910 |